ロード中...
Zoledronic Acid Is Not Equally Potent on Osteoclasts Generated From Different Individuals
Zoledronic acid is a bisphosphonate commonly used to treat bone diseases such as osteoporosis and cancer‐induced bone disease. Patients exhibit a variable sensitivity to zoledronic acid; the underlying explanation for this remains unclear. The objective of this study was to obtain more knowledge in...
保存先:
| 出版年: | JBMR Plus |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7657394/ https://ncbi.nlm.nih.gov/pubmed/33210064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbm4.10412 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|